The largest database of trusted experimental protocols

102 protocols using human methylation 450

1

Differential Methylation in Lung Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Methylation data (HM450K) downloaded from the GDAC database (gdac.broadinstitute.org). According to the TCGA database, CpG probes were collected in the Illumina Human Methylation 450. The probes showed “NA” values were removed. The Illumina Human Methylation 450 data of tumor and adjacent normal samples in lung adenocarcinoma were gathered at the same time by the same standards. Differentially methylation CpG sites between high pyroptosis sample and low pyroptosis sample were defined using R package “ChAMP”.
+ Open protocol
+ Expand
2

Lung Adenocarcinoma Methylation Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to TCGA database, 48,2421 CpG probes were collected in the Illumina Human Methylation 450 of lung adenocarcinoma in total. And we removed 8,8621 probes showed “NA” values in more than 25% samples and ultimately obtained 39,3800 CpG probes. The Illumina Human Methylation 450 data of tumor and adjacent normal samples in lung adenocarcinoma were gathered at the same time by the same standards.
DMCs between tumor tissue and adjacent tissue were defined as false discovery rate (FDR) <0.05 for the comparison between tumor tissue methylation level and adjacent tissue methylation level, and the absolute value of log2 (fold change) >2.5. Bioinformatics analysis including GO enrichment analysis and cluster analysis were also performed. LASSO Cox regression method was analyzed to confirm methylation CpG sites associated with lung adenocarcinoma prognosis based on DMCs. A methylation signature was built according to the sum of each methylation CpG level times the regression coefficient of LASSO Cox regression.19, 20
+ Open protocol
+ Expand
3

Integrative Analysis of Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Matched methylation (platform, Illumina Human Methylation 450), level 3 mRNA-seq (platform, Illumina HiSeq 2000 RNA Sequencing), and corresponding clinical data of PCa patients were obtained from the TCGA database (https://portal.gdc.cancer.gov/) on October 25, 2019, in which 51 samples were normal controls and 495 were PCa (375 samples reported the recurrence status, including 47 from patients with recurrence and 328 from patients without recurrence). Furthermore, methylation datasets of PCa were also downloaded from GEO (http://www.ncbi.nlm.nih.gov/geo/) or EMBL-EBI database (https://www.ebi.ac.uk). A total of 83 samples reporting the status of recurrence (recurrence, n = 17; non-recurrence, n = 68) were included in the GSE26126 dataset (platform, Illumina HumanMethylation27 BeadChip),24 (link) which was used for the validation of modules; there were 108 samples (recurrence, n = 15; non-recurrence, n = 93) in the E-MTAB-6131 dataset (platform, Illumina Human Methylation 450), which was used for validations of both module and survival results.
The annotations of lncRNAs and mRNAs in each dataset were performed using the HUGO Gene Nomenclature Committee (http://www.genenames.org/).25 (link) RNAs with a median expression value of 0 were deleted. The overlapped lncRNAs and mRNAs in all three datasets were used for the following analyses.
+ Open protocol
+ Expand
4

Ovarian Cancer Methylation Data Curation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All ovarian cancer datasets and samples with clinical and methylation information from GEO and TCGA were screened, filtered, and selected by hand. The inclusion criteria were as follows: (1) samples were ovarian cancer tissues from patients with EOC; (2) data were comprised of DNA methylation arrays from Illumina HumanMethylation450 or 27 BeadChip; and (3) complete follow-up information was included to clearly estimate patients’ responses to chemotherapy. The exclusion criteria were as follows: (1) samples were from cell lines or patient-derived xenograft (PDX); (2) data were not from methylation profiling or not from Illumina HumanMethylation450 or 27 BeadChip; (3) data were non-primary downloaded data; and (4) samples were primary resistant, refractory, or using demethylation drugs.
+ Open protocol
+ Expand
5

Promoter Analysis and DNA Methylation in Mesothelioma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analysis of the 241bp of the promoter sequence for potential functional transcription factors was carried out using MatInspector software (Genomatix Software GmbH, Munich, Germany) [25 (link)].
Level 3 normalized DNA methylation data and clinical information was downloaded from The Cancer Genome Atlas (TCGA) data portal on August 10th, 2015. Normalized CALB2 gene expression values (RNAseq) from the same TCGA samples were downloaded from the UCSC cancer genome browser on August 10th, 2015. There were 87 mesotheliomas with available Illumina HumanMethylation450 methylation, gene expression, and clinical data. The majority of tumors were epithelioid histology (n = 57), with n = 23 biphasic, n = 5 diffuse not otherwise specified and n = 2 sarcomatoid tumors. Patient demographic and tumor characteristics are provided in Supplementary Table 1.
+ Open protocol
+ Expand
6

Comparing RRBS and HumanMethylation450 for DNA Methylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In RRBS, DNA is digested with Msp1 restriction enzyme (which is methylation insensitive) and 200 to 400 pair fragments are extracted, bisulfite converted and sequenced. The sequence reads were aligned to the genome using the Novoalign (http://novocraft.com) aligner (onto the in silico converted genome reference) and only uniquely aligning reads were retained. Methylation levels at CpG with a minimum of 5-fold coverage were computed. RRBS computed methylation levels and Illumina HumanMethylation450 methylation levels can be compared directly and without normalization because both methods measure absolute DNA methylation levels. For a total of 2,710 single CpGs that were covered by both an Illumina HumanMethylation450 probe and at least five RRBS reads in Y-iPSCs, we observed a Pearson correlation of 0.79 (Additional file 1: Figure S2). For T-iPSCs, we obtained a total of 2,398 single CpGs that were covered by both methods and a Pearson correlation of 0.81 (Additional file 1: Figure S2).
+ Open protocol
+ Expand
7

Methylation Profiling of Glioblastoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistics were performed in R (version 3.4.4). Survival package (version 2.42) (Therneau and Grambsch, 2000 ) was used for survival risk comparison. Chi-square test was used to evaluate the relationship between methyl-probe and Gender, MGMT, G_CIMP, IDH1, and Treatment. Two-sided t-test was performed for age, PFS_day and os_month. Univariate and multivariate Cox proportional hazards regression were tested on Age, Gender, MGMT status, G-CIMP status, IDH1 mutation, Treatment, Three-CpG panel, Six-CpG panel, and Methyl probe signature. Descriptive statistics with boxplot method was carried out for eliminating outliers of methylation probes. Discovery of significant differential methylation probes was based on the β value of Illumina Human Methylation 450 array by Empirical Bayes (Limma package, version 3.34) between high- and low-risk GBM tumor groups. 1,768 genes of the 3,000 most significant methylation probes (Supplementary Table S3) were determined by the Illumina Human Methylation 450 platform information, and GO analysis was carried out by MetaScape1.
+ Open protocol
+ Expand
8

Methylation Analysis using Illumina HumanMethylation450

Check if the same lab product or an alternative is used in the 5 most similar protocols
For methylation, DNA was prepared using All Prep DNA/RNA/Protein mini kit (Qiagen) and quantified using NanoDrop2000c (Thermo Scientific). 1.5 μg of DNA for each sample was processed at DKFZ (Heidelberg, Germany) by Illumina HumanMethylation450 (Illumina). Data analysis was performed using Integrative Genomics Viewer (IGV) software (Broad Institute) [21 (link), 22 (link)].
+ Open protocol
+ Expand
9

DNA Methylation Analysis of SPG20 in Multiple Cancers

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the DNA methylation data (16–46 independent datasets) belonging to 6 different tumor sites. Each tumor site had its solid tissue normal datasets deposited in TCGA (Figure 1). Their DNA methylation profiles were measured experimentally using the Illumina Infinium Human Methylation 450K platform. The analysis focused on the promoter of the target gene: SPG20. The data mining for our analysis was performed on TCGA by inserting specific filters: DNA methylation (data category) + methylation β values (data type) + methylation array (experimental strategy) + Illumina Human Methylation 450 (platform).
+ Open protocol
+ Expand
10

Correlating SNAPA Expression and DNA Methylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
We downloaded the RNAseq and Illumina Human Methylation 450 datasets from the UCSC Xena database to analyze the correlation between SNAPA expression and DNA methylation. Then, we identified the CpG sites that correlated with mRNA expression and survival rate from the MethSurv web tool (17 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!